
Daniel F. Coughlin
Examiner (ID: 5114, Phone: (571)270-3748 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 626 |
| Issued Applications | 242 |
| Pending Applications | 84 |
| Abandoned Applications | 330 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16695285
[patent_doc_number] => 10945854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Porous composite biomaterials and related methods
[patent_app_type] => utility
[patent_app_number] => 14/078614
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6482
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078614
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/078614 | Porous composite biomaterials and related methods | Nov 12, 2013 | Issued |
Array
(
[id] => 16695285
[patent_doc_number] => 10945854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Porous composite biomaterials and related methods
[patent_app_type] => utility
[patent_app_number] => 14/078614
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6482
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078614
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/078614 | Porous composite biomaterials and related methods | Nov 12, 2013 | Issued |
Array
(
[id] => 10038175
[patent_doc_number] => 09078870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent'
[patent_app_type] => utility
[patent_app_number] => 14/065199
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3334
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14065199
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/065199 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Oct 27, 2013 | Issued |
Array
(
[id] => 11813763
[patent_doc_number] => 09717697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Compositions and methods for the transdermal delivery of methylphenidate'
[patent_app_type] => utility
[patent_app_number] => 14/052190
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6378
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/052190 | Compositions and methods for the transdermal delivery of methylphenidate | Oct 10, 2013 | Issued |
Array
(
[id] => 10365871
[patent_doc_number] => 20150250877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'PATCH'
[patent_app_type] => utility
[patent_app_number] => 14/433939
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8390
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433939 | Patch | Oct 7, 2013 | Issued |
Array
(
[id] => 9408092
[patent_doc_number] => 20140099344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'PROCESS FOR DISPERSING AMINO ACIDS'
[patent_app_type] => utility
[patent_app_number] => 14/038342
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4027
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038342
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038342 | Processing for dispersing amino acids | Sep 25, 2013 | Issued |
Array
(
[id] => 9268792
[patent_doc_number] => 20140023709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE'
[patent_app_type] => utility
[patent_app_number] => 14/034099
[patent_app_country] => US
[patent_app_date] => 2013-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2526
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034099
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/034099 | Oral tablet compositions of dexlansoprazole | Sep 22, 2013 | Issued |
Array
(
[id] => 9529813
[patent_doc_number] => 08753682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Dual release oral tablet compositions of dexlansoprazole'
[patent_app_type] => utility
[patent_app_number] => 14/033956
[patent_app_country] => US
[patent_app_date] => 2013-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2383
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14033956
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/033956 | Dual release oral tablet compositions of dexlansoprazole | Sep 22, 2013 | Issued |
Array
(
[id] => 14323883
[patent_doc_number] => 10292934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition
[patent_app_type] => utility
[patent_app_number] => 14/426669
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426669
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426669 | Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition | Sep 12, 2013 | Issued |
Array
(
[id] => 17177306
[patent_doc_number] => 11154535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Transdermal formulation containing COX inhibitors
[patent_app_type] => utility
[patent_app_number] => 14/026609
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5158
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14026609
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/026609 | Transdermal formulation containing COX inhibitors | Sep 12, 2013 | Issued |
Array
(
[id] => 9205030
[patent_doc_number] => 20140004207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Analgesic Apatitic Calcium-Phosphate Cement'
[patent_app_type] => utility
[patent_app_number] => 14/016910
[patent_app_country] => US
[patent_app_date] => 2013-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8306
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14016910
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/016910 | Analgesic Apatitic Calcium-Phosphate Cement | Sep 2, 2013 | Abandoned |
Array
(
[id] => 10324298
[patent_doc_number] => 20150209302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'ADHESIVE SKIN PATCH'
[patent_app_type] => utility
[patent_app_number] => 14/425449
[patent_app_country] => US
[patent_app_date] => 2013-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6877
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/425449 | ADHESIVE SKIN PATCH | Sep 1, 2013 | Abandoned |
| 13/985994 | TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF | Aug 15, 2013 | Abandoned |
Array
(
[id] => 9311294
[patent_doc_number] => 08652510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Sterilized liquid compositions of cyanoacrylate monomer mixtures'
[patent_app_type] => utility
[patent_app_number] => 13/953011
[patent_app_country] => US
[patent_app_date] => 2013-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17018
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13953011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/953011 | Sterilized liquid compositions of cyanoacrylate monomer mixtures | Jul 28, 2013 | Issued |
Array
(
[id] => 9838592
[patent_doc_number] => 20150030674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'COMPOSITION FOR POLYUNSATURATED FATTY ACIDS ENCAPSULATION AND PROCESS OF PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 13/953079
[patent_app_country] => US
[patent_app_date] => 2013-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3896
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13953079
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/953079 | COMPOSITION FOR POLYUNSATURATED FATTY ACIDS ENCAPSULATION AND PROCESS OF PREPARATION | Jul 28, 2013 | Abandoned |
Array
(
[id] => 9268799
[patent_doc_number] => 20140023716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'Pasty Bone Replacement Material'
[patent_app_type] => utility
[patent_app_number] => 13/940904
[patent_app_country] => US
[patent_app_date] => 2013-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2750
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13940904
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/940904 | Pasty bone replacement material | Jul 11, 2013 | Issued |
Array
(
[id] => 9222508
[patent_doc_number] => 20140017283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'PORATED CARTILAGE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 13/939969
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16194
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939969
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/939969 | PORATED CARTILAGE PRODUCTS | Jul 10, 2013 | Abandoned |
Array
(
[id] => 9798677
[patent_doc_number] => 20150010621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'SUSTAINED RELEASE SOLID DOSAGE PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/935969
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2164
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935969
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935969 | Sustained release solid dosage preparations | Jul 4, 2013 | Issued |
Array
(
[id] => 9211699
[patent_doc_number] => 20140010876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-(METHYL)-2-THIOPHENECARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/930094
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7594
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930094
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/930094 | PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-(METHYL)-2-THIOPHENECARBOXAMIDE | Jun 27, 2013 | Abandoned |
Array
(
[id] => 10240532
[patent_doc_number] => 20150125527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-(METHYL)-2-THIOPHENECARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/412487
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7594
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412487
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412487 | PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-(METHYL)-2-THIOPHENECARBOXAMIDE | Jun 27, 2013 | Abandoned |